Form 8-K - Current report:
SEC Accession No. 0001837607-25-000027
Filing Date
2025-04-08
Accepted
2025-04-08 16:02:28
Documents
14
Period of Report
2025-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aeon-20250403x8k.htm   iXBRL 8-K 36304
  Complete submission text file 0001837607-25-000027.txt   168039

Data Files

Seq Description Document Type Size
2 EX-101.SCH aeon-20250403.xsd EX-101.SCH 4041
3 EX-101.DEF aeon-20250403_def.xml EX-101.DEF 2866
4 EX-101.LAB aeon-20250403_lab.xml EX-101.LAB 17850
5 EX-101.PRE aeon-20250403_pre.xml EX-101.PRE 10672
16 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20250403x8k_htm.xml XML 4998
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 25821891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)